MARC details
000 -LEADER |
fixed length control field |
01480nam a2200241Ia 4500 |
003 - CONTROL NUMBER IDENTIFIER |
control field |
NULRC |
005 - DATE AND TIME OF LATEST TRANSACTION |
control field |
20250520102817.0 |
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION |
fixed length control field |
250520s9999 xx 000 0 und d |
020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
International Standard Book Number |
9780128036204 |
040 ## - CATALOGING SOURCE |
Transcribing agency |
NULRC |
050 ## - LIBRARY OF CONGRESS CALL NUMBER |
Classification number |
RM 301 .C66 2017 |
245 #2 - TITLE STATEMENT |
Title |
A comprehensive guide to toxicology in nonclinical drug development / |
Statement of responsibility, etc. |
edited by Ali S. Faqi |
250 ## - EDITION STATEMENT |
Edition statement |
Second edition. |
260 ## - PUBLICATION, DISTRIBUTION, ETC. |
Place of publication, distribution, etc. |
Amsterdam : |
Name of publisher, distributor, etc. |
Elsevier Science, |
Date of publication, distribution, etc. |
c2017 |
300 ## - PHYSICAL DESCRIPTION |
Extent |
xiii, 971 pages : |
Other physical details |
color illustrations ; |
Dimensions |
29 cm. |
365 ## - TRADE PRICE |
Price amount |
PHP12021.58 |
504 ## - BIBLIOGRAPHY, ETC. NOTE |
Bibliography, etc. note |
Includes bibliographical references and index. |
505 ## - FORMATTED CONTENTS NOTE |
Formatted contents note |
Drug discovery, metabolism, and pharmacokinetics -- Toxicological studies and ind application, and first in-human clinical trial -- Clinical pathology, hispathology, and biomakers -- Biostatis, regulatory toxicology, and role of srudy directors -- Specialty route of administration -- Nonclinical development of monoclonal antibodies, stem cells, oncogenic and non-oncogenic drugs, olignucleotides and vaccines -- Safety evaluation of ocular drugs, botanical products, and medical devices -- Predictive toxicology, toxicmetabolimics, toxicogenomics, and imaging |
520 ## - SUMMARY, ETC. |
Summary, etc. |
Is a valuable refernces designed to provide a complete understanding of all aspects of nonclinical toxicolgy in the development of small molecules and biologics, including vaccines and botanical products. |
650 ## - SUBJECT ADDED ENTRY--TOPICAL TERM |
Topical term or geographic name entry element |
TOXICOLOGY |
700 ## - ADDED ENTRY--PERSONAL NAME |
Personal name |
Faqi, Ali S. |
Relator term |
editor |
942 ## - ADDED ENTRY ELEMENTS (KOHA) |
Source of classification or shelving scheme |
Library of Congress Classification |
Koha item type |
Books |